UPDATE
: Monday, September 7, 2020
Home
Login
Mobile Version
All
Hospital
Pharma
Bio
Korea‘s Bio Industry
Device/ICT
Policy
People
Life science
Special
Innovation for Survival
Korea’s medical culture series
Korea’s New Candidate Drug Watch List
Special Series in Celebration of KBR's 1st Anniversary
Interview with foreign envoys
Special Series in Celebration of KBR’s 2nd Anniversary
Interview with global pharma
Special Series in Celebration of KBR’s 3rd Anniversary
Special Series in Celebration of KBR’s 4th Anniversary
ASCO 2020 Highlights
Opinion
Reporter’s Notebook
Search
트위터
페이스북
RSS
상단여백
제목보기
제목보기
제목+내용
[Column] Digital healthcare for efficient distribution of medical resources
The Ministry of Health and Welfare recently announced a short-term measure ...
by Song Seung-jae
|
2019-09-10 15:46
라인
[Reporter’s Notebook] SillaJen should be ashamed of itself
It was an obvious failure of a drug trial, but the drugmaker said it was no...
by Jeong Sae-im
|
2019-08-07 13:59
라인
[Column] Drug regulator needs adequate expertise to promote medical devices
In the healthcare sector, the medical device industry has the largest growt...
by Korea Biomedical Review
|
2019-07-31 16:59
라인
[Reporter's Notebook] Korean drugmakers should increase presence at global conventions
The 2019 American Society of Clinical Oncology (ASCO) Annual Meeting was be...
by Lee Han-soo
|
2019-06-21 15:57
라인
[Reporter’s Notebook] ‘Wanna know what’s going on with MSD Korea?’
“Is there any trouble between Korea Biomedical Review and MSD Korea?”People...
by Jeong Sae-im
|
2019-05-21 11:44
라인
[Reporter’s Notebook] Roche agreed, MSD and BMS should, too
Immunotherapies have become so effective and popular that some cancer patie...
by Kim Yun-mi
|
2019-05-07 14:30
라인
[Reporter’s Notebook]MFDS incapable of reviewing new drugs?
The most shocking news in the biotech industry in the first half was the mi...
by Lee Hye-seon
|
2019-04-29 16:12
라인
[Column] Measles and fake news
Health authorities are having a rough time unexpectedly because of measles ...
by Park Ji-wook
|
2019-04-16 14:02
라인
[Reporter’s Notebook] Concerns over TB risk rise amid more use of TNF-α inhibitors
Recently, pharmaceutical companies have developed various biological agents...
by Kim Yun-mi
|
2019-03-29 17:21
라인
[Reporter’s Notebook]‘What are you fighting for?’
Most lawmakers, who attend events organized by occupational associations to...
by Song Soo-youn
|
2019-03-25 11:25
라인
[Reporter’s Notebook] TV dramas misportray mental hospitals
In a dark basement without any light, several rooms are arrayed on both sid...
by Song Soo-youn
|
2019-01-18 15:28
라인
[Column] Patient stabbed doctor to death -- things can’t just go on like this
Lim Se-won, a psychiatrist at Kanguk Samsung Hospital, died after a patient...
by Song Hyoung-gon
|
2019-01-03 14:58
라인
[Column]Korea’s healthcare industry: Do flowers blossom in desert, too?
A few days ago, the Ministry of Food and Drug Safety held a conference unde...
by Choi Yoon Sup
|
2018-10-31 11:28
라인
[Column]‘Doctors made patients want to bring CCTVs in operating rooms’
A debate is heating up over installing closed-circuit TVs in operating room...
by Korea Biomedical Review
|
2018-10-16 17:05
라인
[Column] Pyongyang summit prelude for inter-Korean health community
I work in Goyang, a malaria risk area, near the Korean Demilitarized Zone (...
by Korea Biomedical Review
|
2018-09-27 15:08
라인
[Column] What makes telemedicine controversial?
Whether Korea should allow telemedicine has been controversial several time...
by Choi Yoon Sup
|
2018-09-05 15:21
라인
[Reporter’s Notebook] Is Korean market unimportant for Samsung Bioepis?
“Please insert ‘severe’ in front of ‘acute pancreatitis’ in the headline an...
by Nam Doo-hyun
|
2018-08-16 14:24
라인
[Column] Buy expensive and waste your money?
On July 9, the Ministry of Food and Drug Safety banned the sale and manufac...
by Song Hyoung-gon
|
2018-07-16 15:09
라인
[Reporter’s Notebook] Korean medical workers living in fear of violence
Violence is growing in Korean hospitals, including emergency rooms, committ...
by Lee Han-soo
|
2018-07-13 16:34
라인
[Column] Carcinogen threat will continue unless Seoul overhauls generics approval system
The government’s recent ban on hypertension drugs containing a possible car...
by Howard Lee
|
2018-07-12 13:44
-
1
2
3
4
-
176 civic groups furious over government-doctors deal
Amgen Korea wins new indication for acute lymphoblastic leukemia drug
UBcare wins patent for tech to monitor suspected infectious diseases
SCM Lifescience punished for delaying adverse reaction report
176 civic groups furious over government-doctors deal
Amgen Korea wins new indication for acute lymphoblastic leukemia drug
UBcare wins patent for tech to monitor suspected infectious diseases
SCM Lifescience punished for delaying adverse reaction report
여백
Most viewed
1
‘Cyramza helped improve gastric cancer treatment in Korea’
2
‘Reduced-dose prasugrel effective for ACS patients undergoing PCI’
3
Amgen Korea wins new indication for acute lymphoblastic leukemia drug
4
SNUBH develops AI model predicting patients at risk of cerebral aneurysm
5
Novavax releases encouraging phase-1 results on Covid-19 vaccine candidate
6
LG Chem, SK Bioscience end sales partnership with Daewoong
7
UBcare wins patent for tech to monitor suspected infectious diseases
8
176 civic groups furious over government-doctors deal
9
Recovered Covid-19 patients suffer from aftereffects – for long
10
Regulator OKs JW Pharma's rheumarthritis drug for treating giant cell arteries
여백
Opinion
[Column] Correct diagnosis leads to proper treatment
[Column] How ongoing doctors’ strike is different from 20 years ago
A Korean-American Doctor asks: Is Korea truly in 2020?
여백
Back to Top